Health & Medicine | ABNewswire

EcoBlu™ by Ecosense® Among 10 Gifts For This Holiday Season According to Reader’s Digest

The EcoBlu™, is the only digital radon detector with real-time results on a large LED display suitable for short- and long-term monitoring. EcoBlu™ is a true plug-and-play radon detector that provides its first radon result in minutes, not days. Reader’s … Continue reading →

Dr. Rajiv Bajaj’s LASIK Eye Surgery is an Alternative Solution to Regaining Clear Vision.

SMILE is the latest in laser vision correction for myopia (nearsghtedness), providing LASIK-like outcomes in a minimally invasive procedure. Dr. Rajiv Bajaj offers low-cost LASIK eye surgery in Delhi and provides the best LASIK eye surgery in Delhi at affordable … Continue reading →

Item 9 Labs Takes Franchising In A New Direction, Positioning To Become Largest Franchisor In Multi-Billion Dollar Canna-CBD Sector ($INLB)

Item 9 Labs Corp. (OTCQX: INLB) is doing things differently. And by doing so, they have more than changed their revenue-generating dynamic; they have positioned to earn sustainable and recurring revenues from a market opportunity trail they are blazing. And … Continue reading →

Point-of-Care Diagnostics Market Size Share Trends Growth Demand and Competitive Analysis Insights 2022-2029 | DataM Intelligence

Point-of-Care Diagnostics Market – DataM Intelligence Point-of-Care Diagnostics Market is expected to grow at a CAGR of 5% during the forecast period 2022-2029. Market Overview: Point-of-Care Diagnostics Market size was valued around US$ YY million in 2021 and is estimated to … Continue reading →

Colorectal Cancer Pipeline Analysis: 150+ Companies are working to improve the Treatment of Space

DelveInsight’s, “Colorectal Cancer Pipeline Insight, 2022,” report provides comprehensive insights about 150+ companies and 150+ pipeline drugs in the Colorectal Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics … Continue reading →

Multiple Sclerosis Pipeline Insight Report: 100+ Companies are working to improve the treatment

DelveInsight’s, “Multiple sclerosis Pipeline Insight, 2022,” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Multiple sclerosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics … Continue reading →

Sickle Cell Disease Pipeline Landscape Analysis: 40+ Key Players & 50+ Pipeline Drugs

DelveInsight’s, “Sickle Cell Disease Pipeline Insights, 2022” report provides comprehensive insights about 40+ companies and 50+ pipeline drugs in Sickle cell disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product … Continue reading →

Metastatic Renal Cell Carcinoma Pipeline Landscape: 40+ Key Players | DelveInsight

DelveInsight’s, “Metastatic Renal Cell Carcinoma Pipeline Insight, 2022,” report provides comprehensive insights about 40+ companies and 50+ pipeline drugs in the Metastatic Renal Cell Carcinoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Diabetic Macular Edema Pipeline Analysis: 60+ Key Players | DelveInsight

DelveInsight’s, “Diabetic Macular Edema Pipeline Insight, 2022,” report provides comprehensive insights about 60+ companies and 65+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product … Continue reading →

Primary Myelofibrosis Pipeline Analysis: 55+ Companies | DelveInsight

DelveInsight’s, “Primary Myelofibrosis Pipeline Insight, 2022” report provides comprehensive insights about 55+ companies and 55+ pipeline drugs in the Primary Myelofibrosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics … Continue reading →

Friday - April 26, 2024

Category Archives: Health & Medicine